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of cancer risk in the vicinity of pollution sources: 
the experience of a population‑based case–
control study of childhood cancer
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Abstract 
Background: Environmental exposures are related to the risk of some types of cancer, and children are the most 
vulnerable group of people. This study seeks to present the methodological approaches used in the papers of our 
group about risk of childhood cancers in the vicinity of pollution sources (industrial and urban sites). A population‑
based case–control study of incident childhood cancers in Spain and their relationship with residential proximity 
to industrial and urban areas was designed. Two methodological approaches using mixed multiple unconditional 
logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) were developed: (a) 
“near vs. far” analysis, where possible excess risks of cancers in children living near (“near”) versus those living far (“far”) 
from industrial and urban areas were assessed; and (b) “risk gradient” analysis, where the risk gradient in the vicinity of 
industries was assessed. For each one of the two approaches, three strategies of analysis were implemented: “joint”, 
“stratified”, and “individualized” analysis. Incident cases were obtained from the Spanish Registry of Childhood Cancer 
(between 1996 and 2011).
Results: Applying this methodology, associations between proximity (≤ 2 km) to specific industrial and urban zones 
and risk (OR; 95% CI) of leukemias (1.31; 1.04–1.65 for industrial areas, and 1.28; 1.00–1.53 for urban areas), neuroblas‑
toma (2.12; 1.18–3.83 for both industrial and urban areas), and renal (2.02; 1.16–3.52 for industrial areas) and bone 
(4.02; 1.73–9.34 for urban areas) tumors have been suggested.
Conclusions: The two methodological approaches were used as a very useful and flexible tool to analyze the excess 
risk of childhood cancers in the vicinity of industrial and urban areas, which can be extrapolated and generalized to 
other cancers and chronic diseases, and adapted to other types of pollution sources.
Keywords: Cancer risk, Childhood cancer, Methodology, Industrial pollution, Urban pollution, Case–control study
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Environmental exposures are related to the risk of some 
types of cancer [1], and children are the most vulner-
able group of people because they are far more sensi-
tive than adults to toxic chemicals in the environment 
[2, 3]. Moreover, the causes of many childhood cancers 
are largely unknown, so it is necessary epidemiologic 
research as a tool for identifying associations between 
proximity to environmental exposures and the frequency 
of these cancers. In this sense, the biggest population-
based case–control study of incident childhood can-
cer in Spain has been carried out by our group with the 
purpose of analyzing the risk of various types of cancer 
in the proximity of environmental exposures (industrial 
installations, urban areas, road traffic, and agricultural 
crops) [4–12].
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This paper seeks: (a) to present the several methodo-
logical approaches used in our study, summarizing the 
main results; and, (b) to describe our experience study-
ing the risk of childhood cancers in the vicinity of some 
of the pollution point sources, principally industrial and 
urban sites, with the purpose of establishing some guide-
lines and encouraging other researchers to apply these 
methodological tools in their environment-epidemiologic 
studies, using the publicly-available data from the Pollut-
ant Release and Transfer Registers (PRTRs).
Results
Spanish industrial installations included in the European 
PRTR (E-PRTR) were taken into account in the paper. 
A list of industrial groups, together with their E-PRTR 
categories, and number of industrial installations and 
amounts (in kg) released by these industrial plants in 
2009, by groups of carcinogens [according to the Inter-
national Agency for Research on Cancer (IARC)] and 
groups of toxic substances, are shown in Table  1. A list 
including the specific pollutants released to both air and 
water, by category of industrial groups, are described in 
detail in Table 2.
First methodological approach: “Near vs. far” analyses
As a first example of this methodology, the odds ratios 
(ORs) and their 95% confidence intervals (95% CIs) of 
the several childhood cancers studied in our papers in 
relation to the analysis of industrial and urban areas as 
a whole (analysis 1.a), for industrial distances between 2 
and 5  km, are shown in Table  3. Statistically significant 
excess risks were found in children close to: 
(a) industrial facilities for leukemias (OR 1.31; 95% CI 
1.04–1.65 at ≤ 2 km, and OR 1.31; 95% CI 1.03–1.67 
at ≤ 2.5  km) and renal cancer [with ORs ranged 
between 1.85 (95% CI 1.07–3.18) at ≤ 5 km and 2.02 
(95% CI 1.07–3.18) at ≤ 2 km];
(b) urban areas for leukemias (OR 1.28; 95% CI 
1.00–1.53 at ≤ 2  km, OR 1.36; 95% CI 1.02–1.80 
at ≤ 2.5  km, and OR 1.66; 95% CI 1.08–2.55 
at ≤ 4  km) and bone tumors [with ORs ranged 
between 4.02 (95% CI 1.73–9.34) at ≤ 2 km and 4.43 
(95% CI 1.80–10.92) at ≤ 3 km]; and,
(c) intersection area between industrial and urban 
sites for renal cancer (with ORs ranged between 
1.90 (95% CI 1.00–3.59) at ≤ 5  km and 3.14 (95% 
CI 1.50–6.58) at ≤ 2 km), neuroblastoma (OR 2.12; 
95% CI 1.18–3.83 at ≤ 2  km), and bone tumors 
[with ORs ranged between 3.66 (95% CI 1.53–8.75) 
at ≤ 3 km and 3.90 (95% CI 1.48–10.29) at ≤ 2 km].
The ORs of those childhood cancers with statisti-
cally significant results and a number of controls and 
cases ≥ 5, for the “near vs. far” analysis by category of 
industrial group (analysis 1.b) and an industrial distance 
of ≤ 2.5  km, are shown in Table  4. The following posi-
tive associations between certain cancers and residential 
proximity to specific industrial groups were found:
(a) ‘Production and processing of metals, ‘Galvaniza-
tion’, ‘Surface treatment of metals and plastic’, ‘Glass 
and mineral fibers’, and ‘Hazardous waste’ ⇔ leuke-
mias and renal tumors;
(b) ‘Organic chemical industry’ and ‘Urban waste-
water treatment plants’ ⇔ renal and bone tumors;
(c) ‘Pharmaceutical products’ ⇔ leukemias and bone 
tumors;
(d) ‘Surface treatment using organic solvents’ ⇔ leuke-
mias;
(e) ‘Ceramic’ and ‘food and beverage sector’ ⇔ renal 
tumors;
(f ) ‘Mining’ ⇔ neuroblastoma; and,
(g) ‘Cement and lime’ ⇔ bone tumors.
As an example of the “near vs. far” analysis by category 
of pollutants (carcinogens and toxic substances) (analysis 
1.c) for an industrial distance of ≤ 2.5 km, the ORs of leu-
kemias, and renal and bone tumors are shown in Table 5. 
Statistically significant excess risks of leukemias and bone 
tumors were found in the environs of facilities releas-
ing substances included in all IARC groups. In the case 
of bone tumors, the excess risk was only observed near 
industries releasing Group 1-carcinogens. According to 
the categorization of ‘Groups of toxic substances’, statis-
tically significant ORs of leukemias, and renal and bone 
tumors were found in all groups of toxic substances (with 
the exception of plasticizers for renal tumors, and volatile 
organic compounds for bone tumors).
Finally, the ORs of those childhood cancers with signifi-
cant results and a number of controls and cases ≥ 5, for the 
“near vs. far” analysis by specific pollutant (analysis 1.d) and 
an industrial distance of ≤ 2.5  km, are shown in Table  6. 
The highest ORs were found in the environs of industries 
releasing:
(a) ‘Benzo(a)pyrene’ (OR 2.59; 95% CI 1.06–6.16), 
‘Indeno(1,2,3-cd)pyrene’ (OR 2.59; 95% CI 1.06–
6.16), and ‘Tetrachloromethane’ (OR 2.23; 95% CI 
1.35–3.68), for leukemias; and,
(b) ‘1,2-Dichloromethane’ (OR 4.24; 95% CI 1.66–
10.85), ‘Cobalt and compounds’ (OR 3.73; 95% CI 
1.28–10.85), and ‘Polychlorinated biphenyls’ (OR 
3.60; 95% CI 1.10–11.76), for renal tumors.
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Table 2 Specific pollutants released to both air and water, by industrial groups




NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dioxins + furans, trichloroethylene, ben‑
zene,  PAHsb, PMc10,  TSP
d, manganese, vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, 
lead, zinc, dioxins + furans,  PAHsb, toluene, fluoranthene, 
benzo(g,h,i)perylene
Refineries and coke 
ovens
NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dioxins + furans, polychlorinated biphe‑
nyls, 1,1,1‑trichloroethane, trichloromethane, anthracene, 
benzene, naphthalene,  PAHsb, PMc10,  TSP
d, antimony, cobalt, 
manganese, vanadium, ethyl benzene
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 




NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, hexachlorobenzene, lindane, diox‑
ins + furans, polychlorinated biphenyls, anthracene, ben‑
zene, naphthalene,  PAHsb, PMc10,  TSP
d
Arsenic, cadmium, chromium, copper, mercury, nickel, 
lead, zinc, pentachlorophenol, anthracene, nonylphenol, 
naphthalene, organotin compounds,  PAHsb, octylphe‑
nols, fluoranthene, benzo(g,h,i)perylene, benzo(a)pyrene, 
benzo(b)fluoranthene, benzo(k)fluoranthene, indeno(1,2,3‑
cd)pyrene
Galvanization NMVOCa, arsenic, cadmium, chromium, copper, nickel, lead, 
zinc, dioxins + furans, PMc10,  TSPd
Arsenic, cadmium, chromium, copper, nickel, lead, zinc,  PAHsb
Surface treatment of 
metals and plastic
NMVOCa, cadmium, chromium, copper, mercury, nickel, 
lead, zinc, benzene, dichloromethane, 1,2,3,4,5,6‑hexa‑
chlorocyclohexane, tetrachloroethylene, trichloroethylene, 
di‑(2‑ethyl hexyl) phthalate,  PAHsb, PMc10,  TSP
d, manganese, 
vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, anthracene, naphthalene, organotin compounds, 
di‑(2‑ethyl hexyl) phthalate,  PAHsb, fluoranthene, trichlo‑
romethane, toluene, benzo(b)fluoranthene, ethyl benzene, 
xylenes
Mining industry NMVOCa, PMc10,  TSP
d
Cement and lime NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dioxins + furans, polychlorinated biphenyls, 
anthracene, benzene, naphthalene, di‑(2‑ethyl hexyl) 
phthalate,  PAHsb,  PM10,  TSP
d, thallium, antimony, cobalt, 
manganese, vanadium
Copper, zinc
Glass and mineral 
fibers
NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dioxins + furans, polychlorinated biphenyls, 
benzene,  PAHsb, PMc10,  TSP
d, manganese, vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, benzene, ethyl benzene, toluene, xylenes, octylphenols
Ceramic NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, benzene,  PAHsb, PMc10,  TSP
d, thallium, 
antimony, cobalt, manganese, vanadium




NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, 1,2‑dichloroethane, dichloromethane, 
dioxins + furans, tetrachloroethylene, tetrachloromethane, 
trichloromethane, vinyl chloride, anthracene, benzene, 
ethylene oxide, naphthalene,  PAHsb, PMc10,  TSP
d, antimony, 
cobalt, manganese, vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, 
lead, zinc, aldrin, atrazine, chlordane, chlorfenvinphos, 
chlorpyrifos, DDT, 1,2‑dichloroethane, dichloromethane, 
dieldrin, endosulfan, endrin, hexachlorobenzene, hexa‑
chlorobutadiene, 1,2,3,4,5,6‑hexachlorociclohexane, mirex, 
dioxins + furans, simazine, tetrachloroethylene, trichloroben‑
zenes, trichloroethylene, trichloromethane, vinyl chloride, 
anthracene, benzene, brominated diphenylethers, nonyl‑
phenol, ethyl benzene, naphthalene, organotin compounds, 
di‑(2‑ethyl hexyl) phthalate,  PAHsb, toluene, tributyltin, 




NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dichloromethane, dioxins + furans, tetra‑
chloromethane, trichloromethane, PMc10,  TSP
d, antimony
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, hexachlorobenzene, dioxins + furans, trichlorometh‑
ane, organotin compounds,  PAHsb, fluoranthene
Fertilizers NMVOCa, zinc, PMc10,  TSP
d, cobalt
Biocides NMVOCa, dichloromethane, PMc10 Copper, zinc, ethyl benzene, xylenes
Pharmaceutical 
products
NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, 1,2‑dichloroethane, dichloromethane, 
tetrachloromethane, trichloromethane, PMc10,  TSP
d, thallium, 
antimony, cobalt, manganese, vanadium
Chromium, copper, mercury, lead, zinc, 1,2‑dichloroethane, 
dichloromethane, tetrachloroethylene, tetrachlorometh‑
ane, trichloroethylene, trichloromethane, benzene, ethyl 
benzene, toluene, xylenes, naphthalene,  PAHsb, fluoran‑




NMVOCa, lead, PMc10 Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc
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Second methodological approach: “Risk gradient” analyses
As an example of this methodology applied to renal 
tumors, statistically significant radial effects (rise in OR 
with increasing proximity to industries, according to 
concentric rings) in the vicinity of industrial installa-
tions, both overall (analysis 2.a) and by industrial group 
(analysis 2.b), were detected (see Table  7) in all indus-
tries as a whole (p-trend = 0.007), and in the follow-
ing industrial groups: ‘Surface treatment of metals and 
plastic’ (p-trend = 0.012), ‘Urban and waste-water treat-
ment plants’ (p-trend = 0.034), ‘Food and beverage 
Table 2 (continued)
Industrial group Pollutants released by industrial groups
Air Water
Hazardous waste NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, hexachlorobenzene, dioxins + furans, tet‑
rachloroethylene, trichloroethylene, benzene,  PAHsb, PMc10, 
 TSPd, thallium, antimony, cobalt, manganese, vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, dichloromethane, benzene, polychlorinated biphenyls, 
tetrachloroethylene, trichloroethylene, trichloromethane, 
ethyl benzene, naphthalene, organotin compounds,  PAHsb, 
toluene, xylenes
Non‑hazardous waste NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, dioxins + furans, dichloromethane, 
tetrachloroethylene, tetrachloromethane, trichloroethylene, 
vinyl chloride, PMc10,  TSP
d, antimony, cobalt, manganese, 
vanadium
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, alachlor, aldrin, atrazine, chlordane, chlorfenvinphos, 
chlorpyrifos, DDT, 1,2‑dichloroethane, dichloromethane, 
dieldrin, diuron, endosulfan, endrin, heptachlor, hexachlo‑
robenzene, hexachlorobutadiene, 1,2,3,4,5,6‑hexachloro‑
ciclohexane, lindane, mirex, dioxins + furans, pentachlo‑
robenzene, pentachlorophenol, polychlorinated biphenyls, 
simazine, tetrachloroethylene, trichlorobenzenes, trichlo‑
roethylene, trichloromethane, vinyl chloride, anthracene, 
benzene, brominated diphenylethers, nonylphenol, ethyl 
benzene, isoproturon, naphthalene, organotin compounds, 
di‑(2‑ethyl hexyl) phthalate,  PAHsb, toluene, tributyltin, 
triphenyltin, trifluralin, xylenes, octylphenols, fluoranthene, 
isodrin, hexabromobiphenyl
Disposal or recycling 
of animal waste
NMVOCa,  PAHsb, dioxins + furans,  PAHsb, PMc10,  TSPd Zinc, dioxins + furans
Urban waste‑water 
treatment plants
NMVOCa, cadmium, chromium, copper, mercury, nickel, lead, 
dioxins + furans, PMc10
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, atrazine, 1,2‑dichloroethane, diuron, lindane, penta‑
chlorophenol, simazine, tetrachloroethylene, tetrachlo‑
romethane, trichloromethane, anthracene, benzene, nonyl‑
phenol, ethyl benzene, isoproturon, naphthalene, organotin 
compounds, di‑(2‑ethyl hexyl) phthalate,  PAHsb, toluene, 
tributyltin, xylenes, octylphenols, fluoranthene, benzo(g,h,i)
perylene, benzo(a)pyrene, benzo(b)fluoranthene, benzo(k)
fluoranthene, indeno(1,2,3‑cd)pyrene
Paper and wood 
production
NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, lead, zinc, di‑(2‑ethyl hexyl) phthalate, PMc10,  TSP
d
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, tetrachloroethylene, trichlorobenzenes, trichloroeth‑
ylene, trichloromethane, organotin compounds, di‑(2‑ethyl 
hexyl) phthalate,  PAHsb, toluene
Pre‑treatment or dye‑
ing of textiles
NMVOCa, PMc10 Chromium, copper, mercury, nickel, zinc
Tanning of hides and 
skins
NMVOCa Chromium
Food and beverage 
sector
NMVOCa, arsenic, cadmium, chromium, copper, mercury, 
nickel, dioxins + furans, PMc10,  TSPd
Chromium, copper, mercury, nickel, lead, zinc, naphthalene, 





NMVOCa, chromium, copper, nickel, lead, zinc, dichlorometh‑
ane, naphthalene,  PAHsb, PMc10,  TSP
d
Arsenic, cadmium, chromium, copper, mercury, nickel, lead, 
zinc, 1,2‑dichloroethane, trichloroethylene, trichlorometh‑
ane, organotin compounds, toluene, naphthalene,  PAHsb
Production of carbon 
or electro‑graphite
NMVOCa,  PAHsb, PMc10,  TSP
d
a Non‑methane volatile organic compounds
b Polycyclic aromatic hydrocarbons
c Particulate matter
d Total suspended particulate matter
Page 7 of 18García‑Pérez et al. Int J Health Geogr           (2019) 18:12 
Table 3 ORs of childhood tumors in the proximity of industrial and urban areas
Industrial distance 
(km)
Tumor Industrial area Urban area Both
OR (95% CI) OR (95% CI) OR (95% CI)
≤ 5 Leukemias [8] 1.13 (0.83–1.56) 1.41 (0.76–2.61) 1.05 (0.77–1.44)
Renal [5] 1.85 (1.07–3.18) 1.28 (0.35–4.75) 1.90 (1.00–3.59)
Neuroblastoma [7] 1.30 (0.89–1.91) 1.83 (0.78–4.33) 1.41 (0.90–2.20)
Bone [4] NAa NAa NAa
Retinoblastoma [6] 1.33 (0.73–2.44) 2.08 (0.58–7.42) 0.94 (0.45–1.94)
Hepatic [6] 0.60 (0.24–1.48) 0.31 (0.06–1.75) 0.45 (0.14–1.48)
Soft tissue sarcomas [6] 0.60 (0.39–0.93) 0 (0–inf ) 0.81 (0.48–1.37)
Germ cell tumors [6] 1.28 (0.68–2.40) 1.76 (0.33–9.52) 1.31 (0.62–2.76)
Other epithelial neoplasms/melanomas [6] 1.24 (0.29–5.35) 0 (0–inf ) 0.58 (0.09–3.63)
Central nervous system [10] NAa NAa NAa
≤ 4 Leukemias [8] 1.26 (0.94–1.70) 1.66 (1.08–2.55) 1.12 (0.83–1.50)
Renal [5] 1.91 (1.11–3.29) 1.65 (0.71–3.81) 1.92 (1.00–3.71)
Neuroblastoma [7] 1.29 (0.88–1.90) 1.46 (0.82–2.60) 1.42 (0.90–2.25)
Bone [4] NAa NAa NAa
Retinoblastoma [6] 1.31 (0.71–2.40) 1.16 (0.46–2.92) 0.96 (0.45–2.04)
Hepatic [6] 0.60 (0.24–1.48) 0.31 (0.06–1.75) 0.45 (0.14–1.48)
Soft tissue sarcomas [6] 0.59 (0.38–0.93) 0.51 (0.23–1.17) 0.81 (0.47–1.39)
Germ cell tumors [6] 1.24 (0.65–2.34) 0.98 (0.32–3.02) 1.43 (0.67–3.08)
Other epithelial neoplasms/melanomas [6] 1.40 (0.32–6.14) 0 (0–inf ) 0.73 (0.12–4.62)
Central nervous system [10] NAa NAa NAa
≤ 3 Leukemias [8] 1.26 (0.97–1.63) 1.29 (0.92–1.80) 1.10 (0.85–1.42)
Renal [5] 1.96 (1.13–3.39) 1.12 (0.52–2.43) 2.62 (1.34–5.12)
Neuroblastoma [7] 1.28 (0.87–1.89) 1.38 (0.84–2.27) 1.48 (0.91–2.41)
Bone [4] 2.33 (1.17–4.63) 4.43 (1.80–10.92) 3.66 (1.53–8.75)
Retinoblastoma [6] 1.31 (0.71–2.42) 1.33 (0.60–2.93) 0.76 (0.32–1.76)
Hepatic [6] 0.60 (0.24–1.50) 0.44 (0.12–1.66) 0.36 (0.10–1.42)
Soft tissue sarcomas [6] 0.64 (0.41–1.00) 0.60 (0.31–1.15) 0.86 (0.48–1.54)
Germ cell tumors [6] 1.23 (0.64–2.34) 1.28 (0.55–3.00) 1.38 (0.60–3.18)
Other epithelial neoplasms/melanomas [6] 1.45 (0.33–6.37) 0 (0–inf ) 1.08 (0.17–6.93)
Central nervous system [10] NAa NAa NAa
≤ 2.5 Leukemias [8] 1.31 (1.03–1.67) 1.36 (1.02–1.80) 1.07 (0.84–1.36)
Renal [5] 1.97 (1.13–3.42) 1.38 (0.67–2.81) 2.62 (1.30–5.30)
Neuroblastoma [7] 1.33 (0.90–1.97) 1.32 (0.81–2.13) 1.62 (0.98–2.69)
Bone [4] 2.19 (1.10–4.39) 4.08 (1.72–9.64) 3.89 (1.55–9.76)
Retinoblastoma [6] NAa NAa NAa
Hepatic [6] NAa NAa NAa
Soft tissue sarcomas [6] NAa NAa NAa
Germ cell tumors [6] NAa NAa NAa
Other epithelial neoplasms/melanomas [6] NAa NAa NAa
Central nervous system [10] NAa NAa NAa
≤ 2 Leukemias [8] 1.31 (1.04–1.65) 1.28 (1.00–1.53) 1.00 (0.79–1.26)
Renal [5] 2.02 (1.16–3.52) 1.37 (0.69–2.73) 3.14 (1.50–6.58)
Neuroblastoma [7] 1.27 (0.85–1.90) 1.22 (0.76–1.96) 2.12 (1.18–3.83)
Bone [4] 1.97 (0.97–4.02) 4.02 (1.73–9.34) 3.90 (1.48–10.29)
Retinoblastoma [6] 1.38 (0.73–2.59) 1.19 (0.57–2.52) 0.69 (0.26–1.84)
Hepatic [6] 0.65 (0.25–1.68) 0.33 (0.10–1.16) 0.60 (0.13–2.71)
Soft tissue sarcomas [6] 0.62 (0.39–0.99) 0.62 (0.35–1.11) 1.02 (0.52–1.96)
Germ cell tumors [6] 1.15 (0.59–2.26) 1.23 (0.56–2.71) 1.62 (0.61–4.32)
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sector’ (p-trend = 0.040), and ‘Glass and mineral fibers’ 
(p-trend = 0.046).
Discussion
In the present paper, two different methodological 
approaches to perform the statistical analyses in the 
study of risk of childhood cancer in the vicinity of indus-
trial and urban sites have been used by our group. These 
two approaches are complementary, none is preferable to 
the other: the “near vs. far” approach is often used as a 
first step in the study of cancer risk in the environs of pol-
lution sources, whereas the second approach (“risk gra-
dient” analysis) is often used to complement the results 
obtained in the first approach, giving a more detailed 
information about the behavior of the risk in different 
partitions of the “near” zone. Positive results or positive 
associations found in both approaches support and rein-
force the hypothesis of a “real” excess risk in the vicinity 
of the pollution sources analyzed in the study. However, 
the main limitation of these methodological approaches 
is the choice of the radius in the “near vs. far” analysis and 
the critical categorization in concentric rings in the “risk 
gradient” analysis, although our industrial distances are 
in line with the distances used by other authors [13–15]. 
Another limitation is the assumption of the linear trend 
in the risk in the “risk gradient” analysis, something that 
might not be true.
Table 3 (continued)
OR odds ratio, 95% CI 95% confidence interval
a Not applicable
Table 4 ORs of  those childhood tumors with  significant results for  the “near vs. far” analysis by  category of  industrial 
group (≤ 2.5 km)
OR odds ratio, 95% CI 95% confidence interval
Tumor Industrial group (≤ 2.5 km) OR (95% CI)
Leukemias [8] Production and processing of metals 1.69 (1.22–2.34)
Galvanization 1.86 (1.07–3.21)
Surface treatment of metals and plastic 1.62 (1.22–2.15)
Glass and mineral fibers 2.42 (1.49–3.92)
Pharmaceutical products 1.53 (1.00–2.34)
Hazardous waste 1.55 (1.06–2.28)
Surface treatment using organic solvents 1.87 (1.24–2.83)
Renal [5] Production and processing of metals 1.98 (1.03–3.82)
Galvanization 2.66 (1.14–6.22)
Surface treatment of metals and plastic 2.25 (1.24–4.08)
Glass and mineral fibers 2.69 (1.19–6.08)
Ceramic 2.35 (1.06–5.21)
Organic chemical industry 2.22 (1.15–4.26)
Hazardous waste 2.59 (1.25–5.37)
Urban waste‑water treatment plants 2.14 (1.07–4.30)
Food and beverage sector 2.19 (1.18–4.07)
Neuroblastoma [7] Mining 4.67 (1.70–12.81)
Bone [4] Production and processing of metals 3.30 (1.41–7.77)
Surface treatment of metals and plastic 2.59 (1.22–5.50)
Cement and lime 3.89 (1.19–12.77)
Organic chemical industry 3.07 (1.23–7.62)
Pharmaceutical products 2.50 (1.01–6.18)
Urban waste‑water treatment plants 2.61 (1.04–6.54)
Industrial distance 
(km)
Tumor Industrial area Urban area Both
OR (95% CI) OR (95% CI) OR (95% CI)
Other epithelial neoplasms/melanomas [6] 1.82 (0.39–8.44) 0.44 (0.05–3.81) 1.06 (0.12–9.09)
Central nervous system [10] 0.96 (0.73–1.26) 0.90 (0.65–1.24) 1.20 (0.82–1.77)
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In relation to alternative approaches published by other 
authors, Barbone et  al. [16] used an alternative strategy 
in the definition of “exposure” variable for the “near vs. 
far” analyses, based on deciles of the distribution of the 
industrial and urban distances, in a case–control study 
of air pollution and lung cancer in Trieste (Italy). In that 
study, there were one urban nucleus and three industrial 
pollution sources: a shipyard, an iron foundry, and an 
incinerator. Our group adapted their strategy in a simi-
lar case–control study of lung cancer risk and pollution 
in Asturias (Spain) [17, 18], with 48 industrial facilities, 
and 4 urban nuclei with numbers of inhabitants ranged 
between 24,735 and 263,547 inhabitants. However, when 
the sizes of the towns differ considerably among them, 
that methodology causes an irregular distribution of 
cases and controls between the zones around the towns, 
since all towns have the same radius for the “urban area” 
and only a few big cities include the majority of cases and 
controls. Because of this, we consider that our method-
ology is more appropriate for analyses with many towns 
and very different size of the towns (see Fig. 2).
The methodology used in the present paper can be 
extrapolated to other tumors (even in the general popu-
lation) and/or other countries with a National Registry 
of Cancer. In fact, the methodology has already been 
implemented in the ‘MCC-Pollution’ study (included in 
the ‘MCC-Spain’ project [19]), a population-based mul-
ticase–control study that analyzes the risk cancer in 
tumors of high incidence in the Spanish general popula-
tion associated with residential proximity to industrial 
facilities [20]. The diagram of Fig. 1 can also be general-
ized to other chronic diseases which could be related to 
environmental risk factors. In general, our results sug-
gest possible associations between residential proximity 
to specific industrial and urban zones and risk of some 
childhood cancers, especially leukemias, neuroblastoma, 
and renal and bone tumors. In relation to industrial sites, 
this risk was found in children living in the environs of 
several industrial types and industries releasing specific 
carcinogens and toxic substances.
This methodology can be applied directly to other haz-
ardous point sources and toxic hotspots, such as e-waste 
recycling sites and illegal hazardous dumps [21], and it 
can also be easily adapted when the pollution focus is 
not a single point (e.g.: industry, urban nucleus) but a 
line (e.g.: road traffic, motorway, polluted river) [12] or 
a polygon (e.g.: crops treated with pesticides) [9]. Tak-
ing the dispersion of air pollutants into account, the 
methodology allows the possibility of using information 
about wind roses (which include the direction and speed 
Table 5 ORs of  childhood tumors for  the  “near vs. far” 
analysis by category of pollutants (≤ 2.5 km)
OR odds ratio, 95% CI 95% confidence interval
a IARC carcinogenic classification: Group 1: carcinogens to humans (arsenic 
and compounds, cadmium and compounds, chromium and compounds, 
nickel and compounds, lindane, dioxins + furans, polychlorinated biphenyls, 
trichloroethylene, vinyl chloride, benzene, ethylene oxide, polycyclic 
aromatic hydrocarbons, particulate matter  (PM10), total suspended 
particulate matter, and benzo(a)pyrene); Group 2A: probably carcinogenic 
to humans (lead and compounds, dichloromethane, tetrachloroethylene, 
DDT, and hexabromobiphenyl); Group 2B: possibly carcinogenic to 
humans (chlordane, 1,2‑dichloroethane, heptachlor, hexachlorobenzene, 
1,2,3,4,5,6‑hexachlorocyclohexane, mirex, pentachlorophenol, 
tetrachloromethane, trichloromethane, ethyl benzene, naphthalene, di‑(2‑ethyl 
hexyl) phthalate, cobalt and compounds, benzo(b)fluoranthene, benzo(k)
fluoranthene, and indeno(1,2,3‑cd)pyrene)
b Metals (arsenic and compounds, cadmium and compounds, chromium 
and compounds, copper and compounds, mercury and compounds, nickel 
and compounds, lead and compounds, zinc and compounds, thallium, 
antimony, cobalt, manganese, and vanadium); Pesticides (alachlor, aldrin, 
atrazine, chlordane, chlorfenvinphos, chlorpyrifos, DDT, dieldrin, diuron, 
endosulfan, endrin, heptachlor, lindane, mirex, pentachlorobenzene, 
pentachlorophenol, simazine, isoproturon, organotin compounds, 
tributyltin and compounds, triphenyltin and compounds, trifluralin, and 
isodrin); PACs: Polycyclic aromatic chemicals (anthracene, polycyclic 
aromatic hydrocarbons, fluoranthene, benzo(g,h,i)perylene, benzo(a)
pyrene, benzo(b)fluoranthene, benzo(k)fluoranthene, and indeno(1,2,3‑cd)
pyrene); Non‑HPCs: Non‑halogenated phenolic chemicals (nonylphenol and 
nonylphenol ethoxylates, and octylphenols and octylphenol ethoxylates); 
Plasticizers (di‑(2‑ethyl hexyl) phthalate); POPs: Persistent organic 
pollutants (aldrin, chlordane, DDT, dieldrin, endosulfan, endrin, heptachlor, 
hexachlorobenzene, 1,2,3,4,5,6‑hexachlorocyclohexane, lindane, mirex, 
dioxins + furans, pentachlorobenzene, polychlorinated biphenyls, brominated 
diphenylethers, organotin compounds, polycyclic aromatic hydrocarbons, 
hexabromobiphenyl, benzo(a)pyrene, benzo(b)fluoranthene, and benzo(k)
fluoranthene); VOCs: Volatile organic compounds (non‑methane volatile organic 
compounds, 1,2‑dichloroethane, dichloromethane, hexachlorobutadiene, 
tetrachloroethylene, trichlorobenzenes, 1,1,1‑trichloroethane, trichloroethylene, 
trichloromethane, vinyl chloride, benzene, ethyl benzene, ethylene 
oxide, and naphthalene); Solvents (1,2‑dichloroethane, dichloromethane, 
tetrachloroethylene, trichlorobenzenes, 1,1,1‑trichloroethane, trichloroethylene, 
trichloromethane, benzene, ethyl benzene, toluene, and xylenes); Other 





Leukemias [8] Renal [5] Bone [4]
OR (95% CI) OR (95% CI) OR (95% CI)
IARC groupsa
Group 1 1.35 (1.05–1.73) 2.02 (1.15–3.52) 2.28 (1.13–4.62)
Group 2A 1.48 (1.13–1.93) 2.13 (1.19–3.81) 1.97 (0.92–4.22)
Group 2B 1.54 (1.14–2.07) 2.26 (1.22–4.19) 2.20 (0.95–5.07)
Groups of toxic substancesb
Metals 1.40 (1.08–1.80) 2.05 (1.16–3.63) 2.25 (1.09–4.63)
Pesticides 1.61 (1.14–2.27) 2.88 (1.46–5.65) 3.43 (1.42–8.28)
PACs 1.57 (1.16–2.11) 2.16 (1.16–4.03) 2.50 (1.08–5.80)
Non‑HPCs 1.71 (1.21–2.40) 2.18 (1.07–4.45) 3.06 (1.11–8.46)
Plasticizers 1.67 (1.10–2.55) 1.32 (0.53–3.29) 3.46 (1.06–11.27)
POPs 1.58 (1.19–2.10) 2.51 (1.38–4.56) 2.86 (1.31–6.26)
VOCs 1.38 (1.07–1.78) 1.90 (1.08–3.35) 1.98 (0.96–4.09)
Solvents 1.61 (1.20–2.14) 2.37 (1.30–4.34) 2.30 (1.04–5.09)
Other 1.37 (1.06–1.77) 2.04 (1.16–3.59) 2.40 (1.18–4.90)
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of prevailing winds around specific monitoring points) 
together with the distance to refine the definition of 
industrial proximity to pollution sources [17].
To replicate this methodology in other countries, 
in relation to the location of subjects (cases and con-
trols) and pollution sources (industries and towns), the 
children’s domiciles (and geographic coordinates) for 
cases and controls should be provided by the respective 
National Registry of Childhood Tumors and National 
Statistics Institute (see Fig. 1), under collaboration agree-
ments, because they are usually very sensitive data (see 
Availability of data and material section). In the case of 
Table 6 ORs of  those childhood tumors with  significant results for  the  “near vs. far” analysis by  specific carcinogen 
(≤ 2.5 km)
OR odds ratio, 95% CI 95% confidence interval
Pollutant (≤ 2.5 km) IARC group Leukemias [8] Renal [5]
OR (95% CI) OR (95% CI)
Arsenic and compounds 1 1.50 (1.14–1.98) 1.88 (0.85–4.16)
Benzene 1 1.50 (1.05–2.13) 3.15 (1.27–7.81)
Benzo(a)pyrene 1 2.59 (1.09–6.16) 0 (0–inf )
Cadmium and compounds 1 1.50 (1.14–1.98) 2.20 (1.02–4.76)
Chromium and compounds 1 1.49 (1.15–1.93) 2.57 (1.23–5.37)
Nickel and compounds 1 1.46 (1.12–1.89) 2.43 (1.17–5.06)
Particulate matter  (PM10) 1 1.33 (1.02–1.73) 2.51 (1.21–5.20)
PCDD + PCDF (dioxins + furans) 1 1.58 (1.16–2.16) 3.33 (1.42–7.82)
Polychlorinated biphenyls 1 1.30 (0.83–2.04) 3.60 (1.10–11.76)
Polycyclic aromatic hydrocarbons 1 1.54 (1.14–2.08) 2.69 (1.16–6.24)
Total suspended particulate matter 1 1.36 (0.99–1.83) 2.56 (1.17–5.57)
Lead and compounds 2A 1.48 (1.13–1.94) 1.87 (0.85–4.12)
Tetrachloroethylene 2A 1.65 (1.13–2.41) 3.48 (1.30–9.31)
1,2‑Dichloroethane 2B 1.34 (0.89–2.01) 4.24 (1.66–10.85)
Cobalt and compounds 2B 1.02 (0.60–1.73) 3.73 (1.28–10.85)
Di‑(2‑ethyl hexyl) phthalate 2B 1.67 (1.10–2.55) 3.46 (1.06–11.27)
Dichloromethane 2B 1.65 (1.11–2.45) 2.92 (1.14–7.45)
Indeno(1,2,3‑cd)pyrene 2B 2.59 (1.09–6.16) 0 (0–inf )
Naphthalene 2B 1.48 (1.00–2.17) 2.79 (1.01–7.67)
Tetrachloromethane 2B 2.23 (1.35–3.68) 3.30 (1.06–10.29)
Trichloromethane 2B 1.11 (0.71–1.74) 3.30 (1.06–10.29)
Table 7 ORs of childhood renal tumors for the “risk gradient” analyses with significant radial effects
OR odds ratio, 95% CI 95% confidence interval




[0–1 km) [1–2 km) [2–3 km) [3–4 km) [4–5 km] OR p-trend
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
All industries as a whole (analysis 2.a) 2.07 (1.13–3.78) 1.96 (1.09–3.54) 1.74 (0.90–3.35) 1.53 (0.65–3.58) 0.99 (0.35–2.86) 1.16 0.007
Category of industrial group (analysis 2.b)
Surface treatment of metals and plastic 2.60 (1.27–5.33) 1.92 (0.98–3.77) 1.39 (0.70–2.76) 1.53 (0.73–3.21) 1.60 (0.66–3.88) 1.18 0.012
Glass and mineral fibers 3.43 (0.54–21.76) 5.28 (1.63–17.12) 1.19 (0.39–3.60) 1.69 (0.56–5.11) 1.93 (0.67–5.56) 1.28 0.046
Urban waste‑water treatment plants 2.35 (0.57–9.69) 2.23 (0.95–5.28) 1.89 (0.88–4.07) 2.35 (1.15–4.78) 1.46 (0.67–3.18) 1.19 0.034
Food and beverage sector 2.45 (1.04–5.80) 1.86 (0.93–3.72) 1.62 (0.72–3.69) 1.11 (0.43–2.88) 1.65 (0.78–3.48) 1.15 0.040
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the industries, all information about industrial plants, 
including geographic coordinates is publicly available. 
In the case of the towns, the geographic coordinates of 
towns’ centroids are publicly available in the Spanish 
Census. On the other hand, the tools used in the geoc-
oding strategies for all these elements (cases, controls, 
industries, and towns) are open access (see Methods sec-
tion). The methodology used in the paper requires the 
compulsory use of geographic coordinates to be applied 
correctly in the different analyses.
Epidemiological studies of childhood cancer in rela-
tion to proximity to pollution foci have reached great 
importance recently [22–27], and industrial registers of 
toxic substances as the E-PRTR provide a tool for the 
monitoring and surveillance of harmful effects of these 
industrial pollutants, some of them carcinogenic, on the 
human health. In this sense, our experience is being posi-
tive because our study is providing some epidemiological 
clues that residing in the vicinity of certain industrial and 
urban areas may be a risk factor for some types of child-
hood cancers.
With regard to childhood leukemias and the pollu-
tion sources analyzed in our previous papers, our find-
ings about proximity to industrial groups (see Table  4) 
are consistent with other studies in relation to the excess 
risk found in the environs of the metal industry (which 
includes ‘Production and processing of metals’, ‘Galva-
nization’, and ‘Surface treatment of metals and plastic’) 
[28, 29] and installations for the manufacture of ‘Glass 
and mineral fibers’ [28], although other authors did not 
find associations with proximity to incinerators (‘Haz-
ardous waste’) [15]. In relation to specific carcinogens 
and groups of pollutants, some authors found a possible 
increased risk of some types of childhood leukemias in 
children living within 3 km of industrial dichloromethane 
releases (OR 1.64; 95% CI 1.15–2.32) [30], very similar to 
our results for this pollutant at 2.5 km (OR 1.65; 95% CI 
1.11–2.45). Other authors have also found associations 
between benzene exposure and childhood risk of acute 
lymphocytic leukemia [31–33], in line with our results 
(see Table  6). Finally, our findings about proximity to 
Fig. 1 Diagram of the case–control study about the association between proximity to industrial and urban areas and childhood cancer risk
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urban areas (see Table 3), as a proxy of urban pollution, 
are consistent with other papers [12, 34, 35].
With respect to proximity to environmental exposures 
and childhood renal tumors, the few studies focused on 
residential proximity to environmental pollution sources 
did not find associations in relation to hazardous waste 
sites [36] or major roadways [27]. However, some authors 
have found associations between children prenatally 
exposed to polycyclic aromatic hydrocarbons during the 
third trimester and risk of Wilms’s tumor (the main his-
tologic type of childhood renal tumors) [37], something 
that could be related to our findings about this type of 
pollutant (see Table 6).
Insofar as neuroblastoma and environmental exposures 
are concerned, Heck et al. [38] did not find associations 
between exposure to traffic pollution and neuroblastoma. 
In our study about this cancer, the excess risks found in 
the urban areas were not statistically significant (see 
Table  3). However, the same authors found increased 
risks of neuroblastoma with regard to a higher maternal 
exposure to chromium and polycyclic aromatic hydro-
carbons in a radius of 2.5 km, very similar to the non-sta-
tistically excess risks found in our study (data not shown).
In relation to childhood bone tumors and proxim-
ity to industrial areas, there are few studies focused on 
this aspect. Pan et  al. [39] found a higher mortality of 
bone tumors in the environs of petrochemical indus-
tries, whereas Wulff et  al. [40] found an excess risk of 
bone cancer near a smelter. Our results about ‘Organic 
chemical industry’ and ‘Production and processing of 
metals’ yielded high excess risks (see Table  4). With 
respect to childhood bone tumors and proximity to 
urban areas, the majority of the studies existing in the 
literature found significant excess risks in children liv-
ing in urban zones [41–43], in line with our findings 
(see Table 3). However, other authors did not find asso-
ciations between proximity to urban zones and risk of 
childhood bone cancer [44].
As future perspectives, research is still needed on air 
pollution, especially in industrial and urban zones, and 
Fig. 2 Example of exposure areas to industrial and urban zones, for an industrial distance of 2.5 km
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childhood cancer to guide policies for the reduction of 
emission of toxic and carcinogenic substances and pro-
tection of public health. Direct epidemiologic observa-
tion of exposed children for evaluating the magnitude 
of air pollution and large-scale epidemiologic studies 
of environmental exposures and childhood cancer are 
needed [45]. Moreover, surveillance systems for resi-
dential and occupational exposures, and clusters of 
childhood cancers should be implemented to prevent 
childhood cancer risk [46]. Finally, identification and 
control of environmental risk factors that may cause 
cancer in children is the single most effective strategy 
for cancer prevention [23]. As Nelson et  al. [47] say, 
reducing environmental hazards associated with resi-
dential exposures could substantially reduce the human 
burden of childhood cancer and result in significant 
annual and lifetime savings.
Conclusions
The methodological approaches used by our group have 
proved to be very useful and flexible tools to analyze 
the excess risk of childhood cancers in the vicinity of 
industrial and urban areas, which can be extrapolated 
and generalized to other cancers and chronic diseases, 
and adapted to other types of pollution sources.
Methods
A population-based case–control study of incident 
childhood cancers in Spain and their relationship 
with residential proximity to environmental pollution 
sources, in this case, industrial and urban areas, was 
designed. The diagram of our study is shown in Fig. 1: 
the first part depicts the several steps about the study 
subjects, data collection, and definition of the exposure, 
whereas the second part represents the strategies of 
statistical analysis used in our papers [4–8, 10].
Study subjects/data collection/definition of exposure
Step 1 Cases, controls, industries, and towns were 
selected as follows:
(A) Cases: in our case, incident cases of childhood can-
cers (0–14  years) were gathered from the Spanish 
Registry of Childhood Tumors, for Autonomous 
Regions with 100% coverage between 1996 and 
2011: (a) Leukemias, myeloproliferative diseases, 
and myelodysplastic diseases [code I, according 
to the International Classification of Diseases for 
Oncology, 3rd revision (ICCC-3)]; (b) Renal tumors 
(code VI, ICCC-3); (c) Neuroblastoma and other 
peripheral nervous cell tumors (code IV, ICCC-3); 
(d) Malignant bone tumors (code VIII, ICCC-3); 
(e) Retinoblastoma (code V, ICCC-3); (f ) Hepatic 
tumors (code VII, ICCC-3); (g) Soft tissue and 
other extraosseous sarcomas (code IX, ICCC-3); 
(h) Germ cell tumors, trophoblastic tumors, and 
neoplasms of gonads (code X, ICCC-3); (i) Other 
malignant epithelial neoplasms and malignant mel-
anomas (code XI, ICCC-3); and, (j) Central nervous 
system and miscellaneous intracranial and intraspi-
nal neoplasms (code III, ICCC-3) [48].
(B) Controls: from among all single live births regis-
tered in the Spanish National Statistics Institute 
[49] for the study period, six controls per case were 
chosen by simple random sampling, individually 
matched to cases by autonomous region of resi-
dence, sex, and year of birth.
(C) Industries: data on industries were provided from 
the E-PRTR [50] through the Spanish Ministry for 
the Ecological Transition [51], for the year 2009.
(D) Towns: urban locations (towns ≥ 75,000 inhabit-
ants, according to the 2001 Spanish Census [52]) 
were used.
Step 2 The geographic coordinates of cases, controls, 
industries, and towns were geocoded and validated, as 
follows:
(A) Geocoding strategy for cases and controls: each 
child’s last domicile was geocoded using Google 
Maps JavaScript V3 [53]. The obtained latitude and 
longitude coordinates were projected into ETRS89/
Universal Transverse Mercator (UTM) zone 30N 
(EPSG:25830) coordinates using QGIS software 
[54], and subsequently converted into ED50/UTM 
zone 30 (EPSG:23030) coordinates using the R soft-
ware [55]. After this, the coordinates were validated 
and those where the addresses and the coordinates 
matched were chosen. For this validation process, 
the inverse method was applied, getting the home 
addresses of the obtained coordinates and com-
paring these new addresses (street number and 
name, postal code, and city/town name) to the 
original addresses. Lastly, in the final ED50/UTM 
zone 30 coordinates of the children’s domiciles, 
the last digit of the pair of coordinates (X, Y) was 
assigned randomly with the purpose of preserving 
their confidentiality. With respect to the cases, 87% 
of their domiciles were successfully validated. The 
remaining 13% of cases were fairly uniformly dis-
tributed through the different autonomous regions 
and, therefore, we declared that our data were not 
biased in this sense. In relation to the controls, 
initially, only 2% of their addresses could not vali-
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date. Owing to this small number of failures in the 
coordinates, we decided to select more controls to 
replace this small percentage and, finally, we geo-
coded and validated this last group to end up with 
six controls with valid coordinates for each case.
(B) Geocoding strategy for industries: the original geo-
graphic location of each industrial facility included 
in the E-PRTR (longitude/latitude projection) 
was converted into ED50/UTM zone 30 coordi-
nates using the R software [55], and subsequently 
validated following the methodology used for our 
group in the validation of the EPER [56], the indus-
trial register to which the E-PRTR replaced in 2007. 
However, owing to the presence of errors in many 
of the industrial locations, every single address was 
thoroughly checked to ensure that the location 
of the industrial plant was exactly where it should 
be. The following tools were used: (1) the Spanish 
Agricultural Plot Geographic Information System 
(SIGPAC) Viewer [which includes topographic 
maps showing the names of industrial plants, and 
orthophotos (digitalized aerial images)] [57]; (2) 
Google Earth (with the street-view application); 
(3) the “Yellow pages” web page (which allows for 
a search of companies and addresses) [58]; (4) the 
Google Maps server [59]; and (5) the web pages of 
the industrial companies.
(C) Geocoding strategy for towns: municipal centroids 
(not polygonal centroids) of towns in which the 
children resided were used. In Spain, these munici-
pal centroids are located in the centers of the most 
populated areas, where the main church and/or the 
town hall tend to be located. Every single municipal 
centroid was meticulously checked as in the geoco-
ding strategy for industries, using the Google Maps 
server [59], Google Earth, and the SIGPAC viewer 
[57].
Step 3 Sociodemographic variables for all children as 
potential confounders were selected. These variables 
were provided by the 2001 Spanish Census [52] at a cen-
sus tract level (for their unavailability at an individual 
level), and included: (a) percentage of illiteracy; (b) per-
centage of unemployment; and (c) socioeconomic sta-
tus (based on the occupation of the head of the family): 
it ranged from 0.46 to 1.57, where the lower value cor-
responded to the worst socioeconomic status and the 
higher values to better socioeconomic status.
Step 4 Euclidean distances between all children and 
industries (industrial distances) and towns (urban dis-
tances) were calculated using the R software [55].
Step 5 Finally, the “exposure” variable (in our case, the 
proximity to industries, according to several industrial 
distances ‘d’, and proximity to urban areas, according to 
the size of the municipality) was determined. Figure  2 
shows an example of exposure areas to industrial and 
urban sites, for an industrial distance of 2.5 km.
Statistical analysis (strategies)
Two methodological approaches using mixed multiple 
unconditional logistic regression models to estimate ORs 
were developed, using the R software [55]. For each one 
of the two approaches, three strategies of analysis (see 
Fig. 1) were implemented: (a) “Joint” analysis, where the 
risk of childhood cancer in the vicinity of all industries 
and towns as a whole was studied; (b) “Stratified” analy-
sis, where the excess risk in the environs of industrial 
areas was stratified, according to: categories of indus-
trial groups (activities) included in the E-PRTR, catego-
ries of pollutants (industries releasing groups of known 
and suspected carcinogens, and other toxic chemical 
substances), and by specific pollutant; and (c) “Individu-
alized” analysis, where the excess risk in the environs of 
individually selected industrial plants was analyzed.
(1) First methodological approach: “near vs. far” 
analyses.
Potential excess risks of cancers in children living 
near (“near”) versus those living far (“far”) from indus-
trial and urban areas were assessed, comparing the ratio 
between the number of cases and controls in zones 
close to industrial/urban areas and number of cases 
and controls in zones far from these pollutant sources 
 (ORnear vs. far), and adjusting by potential confounders. 
Five “near vs. far” analyses were performed (see Fig. 1):
(a) “Near vs. far” analysis in the proximity of all indus-
trial and urban sites as a whole, for industrial area 
(only), urban area (only), and intersection between 
industrial and urban areas:












1− P(Y = 1)
)





Y is the case−control status (1 = case, 0 = control),
i = 1, . . . , no. of children with tumor c,
n = no. of matching factors and
other potential confounders.
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Each subject i was classified into one of the fol-
lowing five categories of the “exposure” variable 
(IndusUrbancid) for each tumor c and industrial 
distance d : (1) residence in the “industrial area − d 
km (only)”, defined in terms of proximity to indus-
trial facilities, on the basis of the industrial distance 
d ; (2) residence in the “urban area (only)”, taking the 
areas defined by urban distances, according to the 
size and spatial characteristics of the municipalities 
in Spain; (3) residence in the “intersection between 
industrial and urban areas”; (4) residence in the 
“intermediate area”, defined as zones forming a 
“ring” between d and max{D} km around the indus-
tries; and, (5) residence within the “reference area”, 
consisting of zones with children having no indus-
tries within max{D} km of their residences and far 
from urban areas (see Fig.  2). A total of card(D) 
independent models were included in this analysis, 
and all models included matching factors (autono-
mous region of residence as a random effect, and 
sex and year of birth as fixed effects) and the poten-
tial confounders ( MatchConfcij) previously men-
tioned (percentages of illiteracy and unemploy-
ment, and socioeconomic status).
(b) “Near vs. far” analysis by category of industrial 
group, stratifying the excess risk found in industrial 
areas by categories of industrial groups, according 
to the E-PRTR (see Table  1). The statistical model 
is analogous to the previous one. In this case, an 
exposure variable (IndusGroupcikd) for each tumor 
c and industrial distance d was created, in which the 
subject i was classified as resident near the specific 
“industrial group” k (with k = 1, …, no. of indus-
trial groups), if the child resided at ≤ d km from 
any installation belonging to the industrial group in 
question, and resident in the reference area, if the 
child resided at > max{D} km from any industry and 
far from urban areas. A total of dim(k) independ-
ent models were included in this analysis, and the 
remaining variables of the models were the same as 
in the above analysis.
(c) “Near vs. far” analysis by category of pollutants, 
stratifying the risk near industrial areas by the fol-
lowing categories of pollutants: (a) Groups of 
known or suspected carcinogens included in the 
IARC (Group 1—carcinogens to humans, Group 
2A—probably carcinogenic to humans, and Group 
2B—possibly carcinogenic to humans); and, (b) 
Groups of toxic substances created by our groups 
in previous studies [5, 8]: metals, pesticides, poly-
cyclic aromatic chemicals, non-halogenated phe-
nolic chemicals, plasticizers, persistent organic pol-
lutants, volatile organic compounds, solvents, and 
other. The statistical model is analogous to the first 
model. An exposure variable for each tumor c and 
industrial distance d ( SubstanceGroupcild) was cre-
ated, where each subject i was categorized as resi-
dent near industries releasing the specific “group of 
carcinogenic/toxic substances” l (with l = 1, …, no. 
of groups of carcinogens and toxic substances) or 
resident in the reference area, analogous to the pre-
vious analysis. A total of dim(l) independent mod-
els were included in this analysis, and the remaining 
variables of the models were the same as in the first 
model.
(d) “Near vs. far” analysis by specific pollutant. The sta-
tistical model is analogous to the first model. An 
exposure variable for each model ( Pollutantcimd) 
was created, where each subject i was categorized 
as resident near industries releasing the specific 
“pollutant” m (with m = 1, …, no. of specific indus-
trial pollutants) or resident in the “reference area”, 
analogous to the previous analyses. A total of 
dim(m) independent models were included in this 
analysis, and the remaining variables of the models 
were the same as in the first model.
(e) “Near vs. far” analysis by specific industrial instal-
lation, individually. The statistical model is analo-
gous to the first model. An exposure variable for 
each model ( Installationcifd) was created, where 
each subject i was categorized as resident near the 
specific “industry” f  (with f  = 1, …, no. of indus-
trial installations) or resident in the reference area, 
analogous to the previous analyses. The remaining 
variables were the same as in the first model.
(2) Second methodological approach: “Risk gradient” 
analyses.
To assess the risk gradient in the vicinity of industrial 
installations (i.e., the rise in OR with increasing proxim-
ity to industries, according to concentric rings between 
0  km and max{D} km), three analyses were performed 
(see Fig.  1). These analyses were confined to an area of 
10 ∗max{D} km surrounding each installation, and the 
ORs were estimated using mixed multiple unconditional 
logistic regression models.
(a) “Risk gradient” analysis in the proximity of all indus-
tries as a whole: for each tumor c and subject i , a 
new variable, “ minimumdistanceci ” was calculated 
as:





i = 1, . . . , no. of children with tumor c,
f = 1, . . . , no. of industrial installations,
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where industrialdistancecif  is the distance 
between child i and facility f  for each tumor c . 
This new explanatory variable was categorized 
in concentric rings (an example of categoriza-
tion can be: 0 − d1 km, d1 − d2 km, …, dn−1 − dn 
km, and reference: dn − 10 ∗max{D} km, being 
D =
{
d1, d2, . . . , dn−1, dn
}
 the set of the indus-
trial distances). This was included in a first model 
as a categorical variable to estimate the effect of 
the respective distances, and in a second model as 
a continuous variable to ascertain the existence of 
radial effects (rise in OR with increasing proxim-
ity to an installation). The likelihood ratio test was 
applied to compute the statistical significance of 
such minimum distance-related effects.
(b) “Risk gradient” analysis by category of industrial 
group: for each tumor c , subject i , and indus-
trial group k , a total of dim(k) new variables 
“ minimum distance_industrial groupcik ” were cal-
culated as:
where industrial group distancecip is the distance 
between child i and facility p belonging to indus-
trial group k , for each tumor c . These new explana-
tory variables were categorized in concentric rings 
as in the previous analysis. These were included in 
the models as categorical and continuous variables 
(in separate models as in the previous analysis), 
and children that had some industry other than the 
group analyzed within a radius of max{D} km of the 
municipal centroid were excluded.
(c) “Risk gradient” analysis specific industrial instal-
lation: for each tumor c , subject i , and industrial 
installation f  , a new variable industrial distancecif  







i = 1, . . . , no. of children with tumor c,
k = 1, . . . , no. of industrial groups,
p = 1, . . . , no. of facilities belonging
to industrial group k ,
Fig. 3 Example of the “risk gradient” analysis by specific industrial installation (analysis 2.c)
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facility f  for each tumor c . This new explanatory 
variable was categorized in concentric rings as in 
the first analysis and included in the models as both 
a categorical and a continuous variable (in separate 
models as in the first “risk gradient” analysis). Fig-
ure 3 shows an example of this analysis for a specific 
industrial installation.
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